Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -4.03% | 124.42 | 0.0% | $2636.09m | |
| BNGO | BioNano Genomics, Inc. | 15.30% | 9.72 | 0.0% | $1943.24m | |
| GILD | Gilead Sciences, Inc. | 6.08% | 67.18 | 1.0% | $664.89m | |
| CRSP | CRISPR Therapeutics AG | -0.79% | 198.30 | 0.6% | $578.41m | |
| AMGN | Amgen, Inc. | 0.94% | 247.80 | 1.3% | $557.42m | |
| NVAX | Novavax, Inc. | 3.81% | 132.28 | 92.9% | $486.63m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.87% | 532.78 | 2.7% | $470.74m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.42% | 158.93 | 2.0% | $463.97m | |
| ILMN | Illumina, Inc. | 2.45% | 385.55 | 3.5% | $368.01m | |
| BIIB | Biogen, Inc. | 0.96% | 278.50 | 1.7% | $338.21m | |
| SRPT | Sarepta Therapeutics, Inc. | 4.04% | 93.97 | 13.8% | $331.34m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.40% | 226.44 | 1.9% | $328.99m | |
| OCGN | Ocugen, Inc. | 6.36% | 2.36 | 0.0% | $324.74m | |
| BNTX | BioNTech SE | 0.64% | 102.24 | 0.0% | $316.48m | |
| PACB | Pacific Biosciences of California, Inc. | 3.43% | 38.19 | 7.4% | $264.22m |
Company Profile
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.